Dr Garry Laverty
Principal Investigator

Garry graduated with a First Class Honours Masters degree (MPharm) from the School of Pharmacy at Queen's University Belfast in 2005 and a PhD in Pharmaceutics in 2010. After two years working for a Biotech company, Garry returned to the School as a Lecturer and was promoted to Senior Lecturer in 2020. Garry was previously a Visiting Researcher at Bing Xu’s lab (Brandeis University, Department of Chemistry), a world-leading group researching peptide nanomaterials.

Dr Sreekanth Pentlavalli
EPSRC funded Research Fellow

Sree is involved in the development of a novel peptide-mimetic hydrogel platform for use as a long-acting injectable drug delivery systems for diseases with poor medication adherence (e.g. HIV/AIDS).

Dr Sophie Coulter
EPSRC funded Research Fellow

Sophie's work involes the study of peptide hydrogels as multifunctional materials for combined HIV prevention-contraceptive drug delivery. Sophie graduated with a First Class Honours Masters degree (MPHARM) from the School of Pharmacy at Queen's University Belfast in 2015.

Dr Jessica Moore
Invest NI funded Research Fellow

Jessica is researching more efficient approaches in the chemical synthesis and manufacture of our long-acting injectable peptide hydrogel drug delivery system, alongside exploring commercialisation opportunities.

Yuming An
PhD student

Yuming work involves tailoring our peptide-mimetic hydrogels to achieve long-acting drug delivery with multiple HIV and contraceptive drugs for at least 28 days.

Han Sun
PhD

Han Sun is tailoring our peptide-mimetic gels for long-acting drug delivery using several techniques including neutron scattering

OUR RESEARCH IS FUNDED BY